Compare TER & ELV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TER | ELV |
|---|---|---|
| Founded | 1960 | 1944 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Electrical Products | Medical Specialities |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 75.7B | 80.9B |
| IPO Year | 1994 | 2001 |
| Metric | TER | ELV |
|---|---|---|
| Price | $416.27 | $400.64 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 12 | 19 |
| Target Price | $327.75 | ★ $383.56 |
| AVG Volume (30 Days) | ★ 3.5M | 1.4M |
| Earning Date | 04-28-2026 | 04-22-2026 |
| Dividend Yield | 0.17% | ★ 1.83% |
| EPS Growth | ★ 4.52 | N/A |
| EPS | 4.91 | ★ 14.73 |
| Revenue | $3,190,024,000.00 | ★ $199,125,000,000.00 |
| Revenue This Year | $32.19 | N/A |
| Revenue Next Year | $18.88 | $3.07 |
| P/E Ratio | $82.03 | ★ $27.10 |
| Revenue Growth | ★ 13.13 | 12.49 |
| 52 Week Low | $106.30 | $274.89 |
| 52 Week High | $487.91 | $436.24 |
| Indicator | TER | ELV |
|---|---|---|
| Relative Strength Index (RSI) | 59.91 | 56.13 |
| Support Level | $290.68 | $382.77 |
| Resistance Level | $487.91 | $408.00 |
| Average True Range (ATR) | 25.95 | 10.83 |
| MACD | 6.62 | 2.49 |
| Stochastic Oscillator | 98.68 | 90.39 |
Teradyne provides testing equipment, including automated test equipment for semiconductors, system testing for hard disk drives, circuit boards, and electronics systems, and wireless testing for devices. The firm entered the industrial automation market in 2015 and sells collaborative and autonomous robots for factory applications. Teradyne serves numerous end markets and geographies, directly and indirectly, through its products, but its most significant exposure is to semiconductor testing. Teradyne serves vertically integrated, fabless, and foundry chipmakers with its equipment.
Elevance Health remains one of the leading health insurers in the US, providing medical benefits to 45 million medical members at the end of 2025. The company offers employer, individual, and government-sponsored coverage plans. Elevance differs from its peers in its unique position as the largest single provider of Blue Cross Blue Shield branded coverage, operating as the licensee for the Blue Cross Blue Shield Association in 14 states. Through acquisitions, such as the Amerigroup deal in 2012 and MMM in 2021, Elevance's reach expands beyond those states in government-sponsored programs, such as Medicaid and Medicare Advantage plans, too. It is also an emerging player in pharmacy benefit management and other healthcare services.